Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Examine the Value of Broad Agnostic NGS Panel Testing Versus Reimbursed Organ-directed NGS: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Center

NCT04641676 is registered in ClinicalTrials.gov with The Belgian Society of Medical Oncology as lead sponsor.

NCT NCT04641676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04641676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Examine the Value of Broad Agnostic NGS Panel Testing Versus Reimbursed Organ-directed NGS: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Center
Lead sponsor
The Belgian Society of Medical Oncology
Phase
Not applicable
Overall status
Unknown status
Start date
October 9, 2020
Completion date
December 31, 2022
Enrollment
1,000 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

local tumor invasion, metastatic cancer